> top > docs > PMC:7102591 > spans > 12344-13065 > annotations

PMC:7102591 / 12344-13065 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
399 491-493 Gene denotes CS Gene:1431
400 206-208 Gene denotes CS Gene:1431
401 677-679 Gene denotes CS Gene:1431
402 374-376 Gene denotes CS Gene:1431
403 187-195 Species denotes patients Tax:9606
404 307-315 Species denotes patients Tax:9606
405 440-448 Species denotes patients Tax:9606
406 28-57 Disease denotes bacterial or fungal infection MESH:D001424
407 259-263 Disease denotes ARDS MESH:D012128
408 454-462 Disease denotes COVID-19 MESH:C000657245
409 463-472 Disease denotes infection MESH:D007239
410 631-639 Disease denotes COVID-19 MESH:C000657245
411 640-649 Disease denotes infection MESH:D007239

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T64 206-208 Body_part denotes CS http://purl.org/sig/ont/fma/fma284995
T65 374-376 Body_part denotes CS http://purl.org/sig/ont/fma/fma284995
T66 491-493 Body_part denotes CS http://purl.org/sig/ont/fma/fma284995
T67 677-679 Body_part denotes CS http://purl.org/sig/ont/fma/fma284995

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T166 41-57 Disease denotes fungal infection http://purl.obolibrary.org/obo/MONDO_0002041
T167 48-57 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T168 259-263 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T169 454-462 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T170 463-472 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T171 631-639 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T172 640-649 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T96 71-75 http://purl.obolibrary.org/obo/CLO_0037048 denotes CI 1
T97 225-226 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T98 292-293 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T99 388-390 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T96 59-61 Chemical denotes RR http://purl.obolibrary.org/obo/CHEBI_73811
T97 206-208 Chemical denotes CS http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858
T99 374-376 Chemical denotes CS http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858
T101 491-493 Chemical denotes CS http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858
T103 677-679 Chemical denotes CS http://purl.obolibrary.org/obo/CHEBI_73462|http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T64 0-214 Sentence denotes increased rate of secondary bacterial or fungal infection (RR 2·0, 95% CI 1·0–3·8; p = .04), and longer stay in an intensive care unit (mean difference 2.1, 95% CI 1.2–3.1; p < .0001) in patients receiving CS [47].
T65 215-392 Sentence denotes Moreover, a review exploring treatments for ARDS, including six studies with a total of 574 patients, concluded that insufficient evidence exists to recommend CS treatment [48].
T66 393-561 Sentence denotes Overall, no clear reason exists to expect that patients with COVID-19 infection will benefit from CS, and they might be more likely to be harmed with such therapy [49].
T67 562-721 Sentence denotes In fact, current interim guidance from WHO on clinical management of COVID-19 infection advises against the use of CS unless indicated for another reason [10].

2_test

Id Subject Object Predicate Lexical cue
32205186-30917856-4826890 210-212 30917856 denotes 47